In the closing of the recent trading day, Lucid Group (LCID) stood at $2.75, denoting a -1.43% change from the preceding trading day.

Capital Markets increased its price target on Perspective Therapeutics Inc (NYSE:CATX) shares to $20.00, up from the previous $15.00, while maintaining a Buy rating on the stock. The $259.2 million ...

Stockholders of Runway Growth Finance Corp. (NASDAQ:RWAY), a $425 million market cap company with a strong financial health ...

Manufacturing in EV's and Batteries on the Rise to Meet Global Growth Demands January 27, 2025 (Investorideas Newswire) Invest ...

Lucid Motors exceeded Q4 2024 delivery expectations but faces challenges in 2025 due to the removal of the EV tax credit.

In a report released on January 24, John Murphy from Bank of America Securities maintained a Hold rating on Lucid Group (LCID – Research ...

Ballentine Partners LLC reduced its position in shares of Lucid Group, Inc. (NASDAQ:LCID – Free Report) by 44.9% in the ...

The stock market offers several opportunities to turn modest investments into fortunes, provided investors make strategic ...

PAVMed Inc., a medical device company with a market capitalization of just $6.86 million, is currently under scrutiny from ...

It's been a bumpy ride for many electric vehicle (EV) stocks over the past few years, and both Rivian Automotive (NASDAQ: ...

Get ready for Tesla's Q4 earnings report on January 29. Analysts expect revenue of $27.1 billion and $0.77 earnings per share ...

In a report released yesterday, Tom Narayan from RBC Capital maintained a Hold rating on Lucid Group (LCID – Research Report), with a price ...